research use only

Ribociclib succinate CDK inhibitor

Cat.No.S5188

Ribociclib (LEE011) succinate is a highly specific dual inhibitor of CDK4 and CDK6 with IC50 of 10 nM and 39 nM, respectively.
Jump to

Quality Control

Batch: Purity: 99.95%
99.95

Solubility

In vitro
Batch:

DMSO : 13 mg/mL (23.52 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : Insoluble

Ethanol : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 552.63 Formula

C27H36N8O5

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 1374639-75-4 -- Storage of Stock Solutions

Synonyms LEE011 succinate SMILES CN(C)C(=O)C1=CC2=CN=C(NC3=NC=C(C=C3)N4CCNCC4)N=C2[N]1C5CCCC5.OC(=O)CCC(O)=O

Read more about storage stability stock solution CAS number SMILES

Mechanism of Action

Targets/IC50/Ki
CDK4
(Cell-free assay)
10 nM
CDK6
(Cell-free assay)
39 nM
In vitro

LEE011, as dual CDK4/CDK6 inhibitor, significantly inhibits the growth of 12 of 17 neuroblastoma cell lines with mean IC50 of 307 nM. The growth inhibition of neuroblastoma cell lines is primarily cytostatic and is mediated by a G1 cell-cycle arrest and cellular senescence.

In vivo

LEE011 (200 mg/kg daily, p.o.) significantly causes tumor growth delay in mice harboring the BE2C or 1643 xenografts with no weight loss or other signs of toxicity.

References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2026-05-26)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT07237256 RECRUITING
Breast Cancer
UNICANCER
2025-12-18 PHASE3
NCT06849947 NOT_YET_RECRUITING
Breast Cancer Metastatic
Yeon Hee Park
2026-02-01 PHASE2
NCT02813135 RECRUITING
Pediatric Cancer
Gustave Roussy, Cancer Campus, Grand Paris
2016-08-03 PHASE1; PHASE2
NCT07423611 NOT_YET_RECRUITING
Breast Cancer
Fudan University
2026-10-01 PHASE2
NCT03424005 RECRUITING
Metastatic Breast Cancer
Hoffmann-La Roche
2018-03-30 PHASE1; PHASE2
NCT06953882 RECRUITING
HER2 Negative Breast Cancer
Yale University
2025-07-09 PHASE2

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map